Rare Disease Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

By Therapeutic Area (Hematologic Diseases, Cancer, Infectious Diseases, Cardiovascular Diseases, Metabolic Diseases, Endocrine Diseases, Musculoskeletal Diseases, Others), By Route of Administration (Injectable, Oral, Others), By Drug Type (Biologics, Biosimilar, Small Molecules), By Distribution Channel (Specialty Pharmacies, Hospital Pharmacies, Online Pharmacies), By Region, By Competition.

Published	Pages	Publisher	Report code
Oct 2023	190	TechSci Research	ASDR-638180

Published: Oct 2023 - Pages : 190 - Publisher : TechSci Research - Report code : ASDR-638180

1. Novartis AG
2. AstraZeneca PLC
3. Pfizer Inc.
4. Sanofi SA
5. AbbVie Inc
6. Bristol-Myers Squibb Co
7. Bayer AG
8. F Hoffmann-La Roche Ltd.
9. Amgen Inc
10. Eisai Co Ltd
11. Novo Nordisk A/S

Europe Rare Disease Genetic Testing Market: Analysis and Forecast, 2023-2033

This report can be of interest as well:

Europe Rare Disease Genetic Testing Market: Analysis and Forecast, 2023-2033

Published: March, 2024 | Report code: ASDR-661422